Anti-Inflammatory Drugs as Anticancer Agents

Inflammation is strictly associated with cancer and plays a key role in tumor development and progression. Several epidemiological studies have demonstrated that inflammation can predispose to tumors, therefore targeting inflammation and the molecules involved in the inflammatory process could repre...

Full description

Bibliographic Details
Main Authors: Silvia Zappavigna, Alessia Maria Cossu, Anna Grimaldi, Marco Bocchetti, Giuseppe Andrea Ferraro, Giovanni Francesco Nicoletti, Rosanna Filosa, Michele Caraglia
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/7/2605
_version_ 1797571161511428096
author Silvia Zappavigna
Alessia Maria Cossu
Anna Grimaldi
Marco Bocchetti
Giuseppe Andrea Ferraro
Giovanni Francesco Nicoletti
Rosanna Filosa
Michele Caraglia
author_facet Silvia Zappavigna
Alessia Maria Cossu
Anna Grimaldi
Marco Bocchetti
Giuseppe Andrea Ferraro
Giovanni Francesco Nicoletti
Rosanna Filosa
Michele Caraglia
author_sort Silvia Zappavigna
collection DOAJ
description Inflammation is strictly associated with cancer and plays a key role in tumor development and progression. Several epidemiological studies have demonstrated that inflammation can predispose to tumors, therefore targeting inflammation and the molecules involved in the inflammatory process could represent a good strategy for cancer prevention and therapy. In the past, several clinical studies have demonstrated that many anti-inflammatory agents, including non-steroidal anti-inflammatory drugs (NSAIDs), are able to interfere with the tumor microenvironment by reducing cell migration and increasing apoptosis and chemo-sensitivity. This review focuses on the link between inflammation and cancer by describing the anti-inflammatory agents used in cancer therapy, and their mechanisms of action, emphasizing the use of novel anti-inflammatory agents with significant anticancer activity.
first_indexed 2024-03-10T20:35:25Z
format Article
id doaj.art-f4d2573a4c51405ab30e0b48581329ed
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T20:35:25Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-f4d2573a4c51405ab30e0b48581329ed2023-11-19T21:06:01ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-04-01217260510.3390/ijms21072605Anti-Inflammatory Drugs as Anticancer AgentsSilvia Zappavigna0Alessia Maria Cossu1Anna Grimaldi2Marco Bocchetti3Giuseppe Andrea Ferraro4Giovanni Francesco Nicoletti5Rosanna Filosa6Michele Caraglia7Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyDepartment of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyDepartment of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyDepartment of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyMultidisciplinary Department of Medical and Dental Specialties, University of Campania, “Luigi Vanvitelli”, Plastic Surgery Unit, 80138 Naples, ItalyMultidisciplinary Department of Medical and Dental Specialties, University of Campania, “Luigi Vanvitelli”, Plastic Surgery Unit, 80138 Naples, ItalyDepartment of Science and Technology, University of Sannio, 82100 Benevento, ItalyDepartment of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyInflammation is strictly associated with cancer and plays a key role in tumor development and progression. Several epidemiological studies have demonstrated that inflammation can predispose to tumors, therefore targeting inflammation and the molecules involved in the inflammatory process could represent a good strategy for cancer prevention and therapy. In the past, several clinical studies have demonstrated that many anti-inflammatory agents, including non-steroidal anti-inflammatory drugs (NSAIDs), are able to interfere with the tumor microenvironment by reducing cell migration and increasing apoptosis and chemo-sensitivity. This review focuses on the link between inflammation and cancer by describing the anti-inflammatory agents used in cancer therapy, and their mechanisms of action, emphasizing the use of novel anti-inflammatory agents with significant anticancer activity.https://www.mdpi.com/1422-0067/21/7/2605cancerCOX-2 inhibitorsembelininflammation-associated cancer5-LOX inhibitorsNSAIDs
spellingShingle Silvia Zappavigna
Alessia Maria Cossu
Anna Grimaldi
Marco Bocchetti
Giuseppe Andrea Ferraro
Giovanni Francesco Nicoletti
Rosanna Filosa
Michele Caraglia
Anti-Inflammatory Drugs as Anticancer Agents
International Journal of Molecular Sciences
cancer
COX-2 inhibitors
embelin
inflammation-associated cancer
5-LOX inhibitors
NSAIDs
title Anti-Inflammatory Drugs as Anticancer Agents
title_full Anti-Inflammatory Drugs as Anticancer Agents
title_fullStr Anti-Inflammatory Drugs as Anticancer Agents
title_full_unstemmed Anti-Inflammatory Drugs as Anticancer Agents
title_short Anti-Inflammatory Drugs as Anticancer Agents
title_sort anti inflammatory drugs as anticancer agents
topic cancer
COX-2 inhibitors
embelin
inflammation-associated cancer
5-LOX inhibitors
NSAIDs
url https://www.mdpi.com/1422-0067/21/7/2605
work_keys_str_mv AT silviazappavigna antiinflammatorydrugsasanticanceragents
AT alessiamariacossu antiinflammatorydrugsasanticanceragents
AT annagrimaldi antiinflammatorydrugsasanticanceragents
AT marcobocchetti antiinflammatorydrugsasanticanceragents
AT giuseppeandreaferraro antiinflammatorydrugsasanticanceragents
AT giovannifrancesconicoletti antiinflammatorydrugsasanticanceragents
AT rosannafilosa antiinflammatorydrugsasanticanceragents
AT michelecaraglia antiinflammatorydrugsasanticanceragents